Société Générale — Major Shareholding Notification 2026

Apr 23, 2026

National Storage Mechanism | Additional information

RNS Number : 6762B

Societe Generale SA

23 April 2026

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser	SOCIETE GENERALE SA
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.	BAWAG Group AG
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)
(e)   Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure	22/04/2026
(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"	Yes: Permanent TSB Group Holdings plc

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security (Note 3)	€0.01 ordinary shares
	Interests		Short positions
Number	%	Number	%
(1)   Relevant securities owned and/or controlled	137,284	0.18	63,231	0.08
(2)   Cash-settled derivatives	390,990	0.51	346,701	0.45
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell	0	0.00	0	0.00
Total	*730,394	0.95	409,932	0.53

*Include the holding of 202,120 shares on borrow products.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit EUR (Note 5)
€0.01 ordinary shares	Purchase	9	153.6
€0.01 ordinary shares	Purchase	92	155.5
€0.01 ordinary shares	Purchase	36	154.5
€0.01 ordinary shares	Purchase	4	154.5
€0.01 ordinary shares	Purchase	2	154.8
€0.01 ordinary shares	Purchase	15	154.5
€0.01 ordinary shares	Purchase	14	154.6
€0.01 ordinary shares	Purchase	7	152.1
€0.01 ordinary shares	Purchase	8	151.4
€0.01 ordinary shares	Purchase	8	151.7
€0.01 ordinary shares	Purchase	8	152
€0.01 ordinary shares	Purchase	23	152
€0.01 ordinary shares	Purchase	30	151.7
€0.01 ordinary shares	Purchase	50	151.4
€0.01 ordinary shares	Purchase	53	151.5
€0.01 ordinary shares	Purchase	61	151.5
€0.01 ordinary shares	Purchase	63	152
€0.01 ordinary shares	Purchase	71	151.5
€0.01 ordinary shares	Purchase	79	152
€0.01 ordinary shares	Purchase	82	151.7
€0.01 ordinary shares	Purchase	91	152.1
€0.01 ordinary shares	Purchase	98	152
€0.01 ordinary shares	Purchase	117	152
€0.01 ordinary shares	Purchase	595	150.9
€0.01 ordinary shares	Purchase	2	151.9
€0.01 ordinary shares	Purchase	2	152
€0.01 ordinary shares	Purchase	3	152.1
€0.01 ordinary shares	Purchase	7	152.1
€0.01 ordinary shares	Purchase	8	151.7
€0.01 ordinary shares	Purchase	8	152
€0.01 ordinary shares	Purchase	10	152
€0.01 ordinary shares	Purchase	14	152
€0.01 ordinary shares	Purchase	20	152.1
€0.01 ordinary shares	Purchase	22	152.1
€0.01 ordinary shares	Purchase	27	152
€0.01 ordinary shares	Purchase	30	151.9
€0.01 ordinary shares	Purchase	32	151.9
€0.01 ordinary shares	Purchase	32	152
€0.01 ordinary shares	Purchase	35	152
€0.01 ordinary shares	Purchase	36	152.1
€0.01 ordinary shares	Purchase	39	151.8
€0.01 ordinary shares	Purchase	40	152
€0.01 ordinary shares	Purchase	41	151.7
€0.01 ordinary shares	Purchase	41	152
€0.01 ordinary shares	Purchase	42	152
€0.01 ordinary shares	Purchase	49	151.7
€0.01 ordinary shares	Purchase	53	152
€0.01 ordinary shares	Purchase	53	152
€0.01 ordinary shares	Purchase	57	152.1
€0.01 ordinary shares	Purchase	60	152
€0.01 ordinary shares	Purchase	60	152.1
€0.01 ordinary shares	Purchase	63	151.7
€0.01 ordinary shares	Purchase	72	151.7
€0.01 ordinary shares	Purchase	72	151.8
€0.01 ordinary shares	Purchase	72	152
€0.01 ordinary shares	Purchase	72	152
€0.01 ordinary shares	Purchase	72	152.1
€0.01 ordinary shares	Purchase	72	152.1
€0.01 ordinary shares	Purchase	81	152
€0.01 ordinary shares	Purchase	82	152
€0.01 ordinary shares	Purchase	83	151.7
€0.01 ordinary shares	Purchase	115	151.7
€0.01 ordinary shares	Purchase	166	152
€0.01 ordinary shares	Purchase	173	152
€0.01 ordinary shares	Purchase	263	152.1
€0.01 ordinary shares	Purchase	25	152.4
€0.01 ordinary shares	Sale	1,600	153.14552
€0.01 ordinary shares	Sale	9	153.6
€0.01 ordinary shares	Sale	3,159	150.86982
€0.01 ordinary shares	Sale	145	150.86979
€0.01 ordinary shares	Sale	567	150.87737
€0.01 ordinary shares	Sale	46	150.9
€0.01 ordinary shares	Sale	92	150.9
€0.01 ordinary shares	Sale	92	150.9
€0.01 ordinary shares	Sale	92	150.9
€0.01 ordinary shares	Sale	92	150.9
€0.01 ordinary shares	Sale	92	150.9
€0.01 ordinary shares	Sale	92	151.4
€0.01 ordinary shares	Sale	92	155.5
€0.01 ordinary shares	Sale	185	150.9
€0.01 ordinary shares	Sale	185	150.9
€0.01 ordinary shares	Sale	185	150.9
€0.01 ordinary shares	Sale	100	153.2
€0.01 ordinary shares	Sale	169	156.3
€0.01 ordinary shares	Sale	75	151.6
€0.01 ordinary shares	Sale	15	152.8
€0.01 ordinary shares	Sale	159	150.9
€0.01 ordinary shares	Sale	95	150.9
€0.01 ordinary shares	Sale	23	151.8
€0.01 ordinary shares	Sale	28	153
€0.01 ordinary shares	Sale	29	153.4
€0.01 ordinary shares	Sale	30	151.7
€0.01 ordinary shares	Sale	30	153.1
€0.01 ordinary shares	Sale	31	152.7
€0.01 ordinary shares	Sale	33	151.9
€0.01 ordinary shares	Sale	33	151.9
€0.01 ordinary shares	Sale	33	152.1
€0.01 ordinary shares	Sale	33	152.2
€0.01 ordinary shares	Sale	33	152.5
€0.01 ordinary shares	Sale	33	152.5
€0.01 ordinary shares	Sale	33	152.8
€0.01 ordinary shares	Sale	33	152.8
€0.01 ordinary shares	Sale	33	153.1
€0.01 ordinary shares	Sale	33	153.1
€0.01 ordinary shares	Sale	33	153.5
€0.01 ordinary shares	Sale	33	154
€0.01 ordinary shares	Sale	33	154.6
€0.01 ordinary shares	Sale	38	153.2
€0.01 ordinary shares	Sale	39	154
€0.01 ordinary shares	Sale	40	153.4
€0.01 ordinary shares	Sale	41	152.8
€0.01 ordinary shares	Sale	44	152.7
€0.01 ordinary shares	Sale	51	152.9
€0.01 ordinary shares	Sale	66	151.6
€0.01 ordinary shares	Sale	67	153.6
€0.01 ordinary shares	Sale	69	153.8
€0.01 ordinary shares	Sale	70	153.2
€0.01 ordinary shares	Sale	9	153
€0.01 ordinary shares	Sale	13	154.6
€0.01 ordinary shares	Sale	14	151.6
€0.01 ordinary shares	Sale	14	151.7
€0.01 ordinary shares	Sale	14	151.8
€0.01 ordinary shares	Sale	14	151.8
€0.01 ordinary shares	Sale	14	151.9
€0.01 ordinary shares	Sale	14	151.9
€0.01 ordinary shares	Sale	14	152
€0.01 ordinary shares	Sale	14	152.2
€0.01 ordinary shares	Sale	14	152.3
€0.01 ordinary shares	Sale	14	152.7
€0.01 ordinary shares	Sale	14	152.8
€0.01 ordinary shares	Sale	14	152.9
€0.01 ordinary shares	Sale	14	152.9
€0.01 ordinary shares	Sale	14	152.9
€0.01 ordinary shares	Sale	14	153
€0.01 ordinary shares	Sale	14	153
€0.01 ordinary shares	Sale	14	153
€0.01 ordinary shares	Sale	14	153
€0.01 ordinary shares	Sale	14	153
€0.01 ordinary shares	Sale	14	153.1
€0.01 ordinary shares	Sale	14	153.1
€0.01 ordinary shares	Sale	14	153.2
€0.01 ordinary shares	Sale	14	153.3
€0.01 ordinary shares	Sale	14	153.6
€0.01 ordinary shares	Sale	14	153.6
€0.01 ordinary shares	Sale	15	152.9
€0.01 ordinary shares	Sale	15	153.3
€0.01 ordinary shares	Sale	16	152.9
€0.01 ordinary shares	Sale	17	152.1
€0.01 ordinary shares	Sale	17	152.9
€0.01 ordinary shares	Sale	18	151.9
€0.01 ordinary shares	Sale	19	153.1
€0.01 ordinary shares	Sale	22	152.2
€0.01 ordinary shares	Sale	22	152.9
€0.01 ordinary shares	Sale	23	152.5
€0.01 ordinary shares	Sale	31	152.9
€0.01 ordinary shares	Sale	31	154
€0.01 ordinary shares	Sale	32	153.1
€0.01 ordinary shares	Sale	33	153.2
€0.01 ordinary shares	Sale	42	153.9
€0.01 ordinary shares	Sale	58	153.6
€0.01 ordinary shares	Sale	11	152.7
€0.01 ordinary shares	Sale	16	152.7
€0.01 ordinary shares	Sale	46	153
€0.01 ordinary shares	Sale	1	151.8
€0.01 ordinary shares	Sale	1	153.2
€0.01 ordinary shares	Sale	2	151.6
€0.01 ordinary shares	Sale	6	151.6
€0.01 ordinary shares	Sale	6	151.6
€0.01 ordinary shares	Sale	6	152
€0.01 ordinary shares	Sale	6	153
€0.01 ordinary shares	Sale	6	153
€0.01 ordinary shares	Sale	6	153
€0.01 ordinary shares	Sale	7	151.8
€0.01 ordinary shares	Sale	8	151.8
€0.01 ordinary shares	Sale	8	152
€0.01 ordinary shares	Sale	8	153
€0.01 ordinary shares	Sale	8	153.2
€0.01 ordinary shares	Sale	9	151.8
€0.01 ordinary shares	Sale	9	153
€0.01 ordinary shares	Sale	9	153.2
€0.01 ordinary shares	Sale	11	151.8
€0.01 ordinary shares	Sale	14	151.6
€0.01 ordinary shares	Sale	19	151.9
€0.01 ordinary shares	Sale	20	152
€0.01 ordinary shares	Sale	24	152.4
€0.01 ordinary shares	Sale	30	152.9
€0.01 ordinary shares	Sale	185	150.9
€0.01 ordinary shares	Sale	462	150.9
€0.01 ordinary shares	Sale	401	150.9

Ap29

(b)           Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position	Number of reference securities (Note 6)	Price per unit EUR (Note 5)
€0.01 ordinary shares	CFD	Reducing a long position	9	153.6
€0.01 ordinary shares	CFD	Reducing a short position	1,600	153.14552
€0.01 ordinary shares	CFD	Increasing a long position	9	153.6
€0.01 ordinary shares	CFD	Increasing a long position	3,159	150.86982
€0.01 ordinary shares	CFD	Increasing a long position	145	150.86979
€0.01 ordinary shares	CFD	Increasing a long position	567	150.87737
€0.01 ordinary shares	Listed Call Warrant	Increasing a long position	5	20.6
€0.01 ordinary shares	Listed Call Warrant	Increasing a long position	1.1	63.3
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	2.5	50.4
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	1	111.9
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	3,200	27.9
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	130	7.6
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	5	74.6

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates (Note 6)	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii)           Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit (Note 5)

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of relevant security	Nature of dealing e.g. subscription, conversion, exercise	Details	Price per unit (if applicable) (Note 5)

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

(c)           Attachments

Is a Supplemental Form 8 attached?	NO

Date of disclosure	23/04/2026
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap31

NOTES ON FORM 8.3

1.             See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

2.             See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

3.             See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

4.             See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

5.             If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

6.             See Rule 2.5(d) of Part A of the Rules.

7.             If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPFIFIASRIVFIR